Skip to main content
Clinical Trials/CTRI/2022/10/046230
CTRI/2022/10/046230Not yet recruitingPhase 2/3

Randomized open controlled clinical study to evaluate the efficacy of Dadimadi Ardra Twak Lepa for external use in Vyanga Vyadhi

Dr Mukesh Dilip Chaudhari1 site in 1 country100 target enrollmentStarted: October 15, 2022Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Enrollment
100
Locations
1
Primary Endpoint
Decrease in Sign and symptoms of Vyang Vyadhi.

Study Overview

Brief Summary

This study is a Randomized open controlled clinical study to evaluate  the efficacy of Dadimadi Adra Twak Lepa for external use in Vyang Vyadhi . Study will be carried in opd of kayachiktsha department of yashwant ayurvedic college and hospital , kodoli. The observation would be drawn on the basis of treatment given.

Study Design

Study Type
Interventional
Allocation
Adaptive randomization, such as minimization
Masking
Not Applicable

Eligibility Criteria

Ages
20.00 Year(s) to 60.00 Year(s) (—)

Inclusion Criteria

  • Age group 20 to
  • Irrespective of Gender.
  • Patient with classical signs and symptoms of Vyanga vyadhi 4)Chronicity less than 3 years.

Exclusion Criteria

  • with present history of skin disease eg Psoriasis, Acne Vulgaris, Dermatitis, Vitiligo etc.
  • related to face.
  • Person suffering from any infective or contagious skin disease or under medication with antibiotic, antifungal and steroids.
  • Patient of uncontrolled Hormonal disease.
  • Any skin allergy.

Outcomes

Primary Outcomes

Decrease in Sign and symptoms of Vyang Vyadhi.

Time Frame: 30 days

Secondary Outcomes

  • Decrease in Dark patches on face.(30 days)

Investigators

Sponsor
Dr Mukesh Dilip Chaudhari
Sponsor Class
Other [self]

Study Sites (1)

Loading locations...

Similar Trials